title: Liver-first strategy for synchronous colorectal liver metastases - an intention-to-treat analysis.
abstract: The liver-first strategy signifies resection of liver metastases before the primary colorectal cancer. The aim of the present study was to compare failure to complete intended treatment and survival in liver-first and classical strategies.
  
  
  
  All patients with colorectal cancer and synchronous liver metastases planned for sequential radical surgery in a single institution between 2011 and 2015 were included.
  
  
  
  A total of 109 patients were presented to a multidisciplinary team conference (MDT) with un-resected colorectal cancer and synchronous liver metastases. Seventy-five patients were planned as liver-first, whereas 34 were recommended the classical strategy. Twenty-six patients (35%) failed to complete treatment in the liver-first group compared to 10 patients in the classical group (P = 0.664). Reason for failure was most commonly disease progression. A total of 91 patients had the primary tumor resected before the liver metastases of which 67 before referral and 24 after allocation at MDT. Median survival after diagnosis in this group was 60 (48-73) months compared to 46 (31-60) months in the group operated with liver-first strategy (n = 49), (P = 0.310).
  
  
  
  Up to 35% of patients with colorectal cancer and synchronous liver metastases do not complete the intended treatment of liver and bowel resections, irrespective of treatment strategy.
authors.affiliation: Lund University, Skane University Hospital, Department of Clinical Sciences Lund, Surgery, Lund, Sweden. Electronic address: christian.sturesson@med.lu.se.
authors.forename: Christian
authors.initials: C
authors.lastname: Sturesson
authors.affiliation: Lund University, Skane University Hospital, Department of Clinical Sciences Lund, Surgery, Lund, Sweden.
authors.forename: Valentinus T
authors.initials: VT
authors.lastname: Valdimarsson
authors.affiliation: Lund University, Skane University Hospital, Department of Clinical Sciences Lund, Surgery, Lund, Sweden.
authors.forename: Erik
authors.initials: E
authors.lastname: Blomstrand
authors.affiliation: Lund University, Skane University Hospital, Department of Clinical Sciences Lund, Surgery, Lund, Sweden.
authors.forename: Sam
authors.initials: S
authors.lastname: Eriksson
authors.affiliation: Lund University, Skane University Hospital, Department of Clinical Sciences Lund, Surgery, Lund, Sweden.
authors.forename: Jan H
authors.initials: JH
authors.lastname: Nilsson
authors.affiliation: Lund University, Skane University Hospital, Department of Clinical Sciences Malmö, Surgery, Malmö, Sweden.
authors.forename: Ingvar
authors.initials: I
authors.lastname: Syk
authors.affiliation: Lund University, Skane University Hospital, Department of Clinical Sciences Lund, Surgery, Lund, Sweden.
authors.forename: Gert
authors.initials: G
authors.lastname: Lindell
mesh_terms: D000368:Aged; D003082:Colectomy / Q000009:adverse effects / Q000401:mortality; D015179:Colorectal Neoplasms / Q000401:mortality / Q000473:pathology* / Q000601:surgery*; D018450:Disease Progression; D005260:Female; D006498:Hepatectomy / Q000009:adverse effects / Q000401:mortality; D006801:Humans; D008113:Liver Neoplasms / Q000401:mortality / Q000556:secondary* / Q000601:surgery*; D008297:Male; D059146:Metastasectomy / Q000009:adverse effects / Q000379:methods* / Q000401:mortality; D008875:Middle Aged; D012189:Retrospective Studies; D012307:Risk Factors; D013548:Sweden; D013997:Time Factors; D016896:Treatment Outcome